BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Biocryst Pharmaceuticals 

2190 Parkway Lake Drive

Birmingham  Alabama  35244  U.S.A.
Phone: 205-444-4600 Fax:


SEARCH JOBS


Industry
Biotechnology


Collaborations

Affinimark Technologies Inc. 





 Company News
Biocryst Pharmaceuticals (BCRX) Announces Nature Publication Demonstrating Efficacy Of BCX4430 In A Non-Human Primate Model Of Filovirus Infection 3/3/2014 8:58:12 AM    More...
Biocryst Pharmaceuticals (BCRX) Presents BCX4161 Phase 1 Trial And Kallikrein Inhibition Assay Results 3/3/2014 8:56:25 AM    More...
Biocryst Pharmaceuticals (BCRX) Reports Fourth Quarter And Full Year 2013 Financial Results 2/26/2014 9:13:21 AM    More...
Biocryst Pharmaceuticals (BCRX) Announces Peramivir NDA Acceptance By The FDA 2/25/2014 9:00:36 AM    More...
Biocryst Pharmaceuticals (BCRX) To Present At Three Upcoming Investor Conferences 2/20/2014 8:57:15 AM    More...
Biocryst Pharmaceuticals (BCRX) to Announce Fourth Quarter And 2013 Financial Results February 26 2/12/2014 9:26:09 AM    More...
Biocryst Pharmaceuticals (BCRX) To Present At J.P. Morgan Healthcare Conference 1/3/2014 9:47:35 AM    More...
Biocryst Pharmaceuticals (BCRX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of BCX4430 To Treat Marburg Virus Disease 12/30/2013 8:30:42 AM    More...
Biocryst Pharmaceuticals (BCRX) Files For Government-Funded Flu Treatment 12/20/2013 8:15:22 AM    More...
Biocryst Pharmaceuticals (BCRX) Advances Second Generation Oral Plasma Kallikrein Inhibitors For Hereditary Angioedema Into Preclinical Development 12/18/2013 9:39:23 AM    More...
12345678910...

//-->